Back to 
MORGAN STANLEY
MORGAN STANLEY
TTRX3 quarters
Position history for MORGAN STANLEY's holdings in TURN THERAPEUTICS INC
Yes. Morgan Stanley holds 11,347 shares of TTRX (Turn Therapeutics), worth $82,833, as of its Q2 2026 13F filing. It increased the position by 1,347 shares (+13.5%) from Q1 2026. Morgan Stanley has held TTRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$82,833
Current Shares
11,347
Total Value Change
+$43,433
Total Shares Change
+1,347
Quarter-by-Quarter History
Other major holders of TTRX: IEQ CAPITAL, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, BlackRock, Inc.